Did you know that the incredible medications, Mounjaro and Ozempic, have their origins from a venomous lizard
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
What is changing in your coverage of GLP-1s
The in vivo half-life study in hemizygous human FcRn Tg32 mice was performed at The Jackson Laboratory (JAX Services, Bar Harbor, ME, USA), which was approved by the Animal Care and Use Committee at The Jackson Laboratory
Open Communication Before you come in for your consultation at Renew Aesthetics, its always important to familiarize yourself with your medical history
McKeag NA, McKinley MC, Harbinson MT, McGinty A, Neville CE, Woodside JV, et al